Hennion & Walsh Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $880K | Buy |
|
|||||
|
2025
Q2 | $321K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $512K | Sell |
|
|||||
|
2024
Q2 | $332K | Sell |
|
|||||
|
2024
Q1 | $314K | Buy |
|
|||||
|
2023
Q4 | $321K | Sell |
|
|||||
|
2023
Q3 | $678K | Sell |
|
|||||
|
2023
Q2 | $1.25M | Buy |
|
|||||
|
2023
Q1 | $1.8M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Buy |
|
|||||
|
2022
Q3 | $1.09M | Sell |
|
|||||
|
2022
Q2 | $1.11M | Buy |
|
|||||
|
2022
Q1 | $1.07M | Buy |
|
|||||
|
2021
Q4 | $777K | Buy |
|